stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) EV/FCF
As of 5 November 2026, Stevanato Group S.p.A. (STVN) trades at a EV/FCF of −453×. Over the past ten years it has ranged from −697× (September 2026) to 435× (January 2026); the current reading is higher than 7% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 402× | — |
| FY2024 | −37.5× | — |
| FY2023 | −20.3× | — |
| FY2022 | −31.2× | — |
| FY2021 | 216× | 1,245.60% |
| FY2020 | 16.0× | 0.00% |
| FY2019 | 16.0× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | −697× | — |
| Jun 2026 | −154× | — |
| Mar 2026 | −406× | — |
| Dec 2025 | 402× | — |
| 22 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| MMED MiniMed Group, Inc. compare | −10.9× |
| NVST Envista Holdings Corporation compare | 18.0× |
| MMSI Merit Medical Systems, Inc. compare | 24.7× |
| ICUI ICU Medical, Inc. compare | 25.5× |
| ATRC AtriCure, Inc. compare | 125× |
| WRBY Warby Parker Inc. compare | 139× |
| TFX Teleflex Incorporated compare | 172× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on STVN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement